BACKGROUND: Tuberculosis (TB) is a serious world-wide health problem, causing millions of deaths every year. Metabolomics is a relatively new approach to identify disease specific biomarkers. However, there is little information available on metabolite biomarkers in TB. In this study, we used gas chromatography/time-of-flight mass spectrometry (GC/TOF-MS) to identify serum metabolite biomarkers associated with the active state of TB. METHODS: Potential biomarkers were selected by comparing serum metabolites in 10 healthy donors with 10TB patients, and in 6TB patients before and after treatment. Selected biomarkers were then validated using a larger population of samples from 120 healthy donors and 120TB patients derived from different clinical backgrounds RESULTS: The 5-oxoproline level was consistently low in patients with active TB. Further validation in larger population of clinical samples showed that 5-oxoproline was associated with pathological damage of the lung but not with age, sex, or bacterial burden in TB patients. CONCLUSIONS: Serum 5-oxoproline may be a useful biomarker for active TB and pathological damage of the lung.
BACKGROUND:Tuberculosis (TB) is a serious world-wide health problem, causing millions of deaths every year. Metabolomics is a relatively new approach to identify disease specific biomarkers. However, there is little information available on metabolite biomarkers in TB. In this study, we used gas chromatography/time-of-flight mass spectrometry (GC/TOF-MS) to identify serum metabolite biomarkers associated with the active state of TB. METHODS: Potential biomarkers were selected by comparing serum metabolites in 10 healthy donors with 10TB patients, and in 6TB patients before and after treatment. Selected biomarkers were then validated using a larger population of samples from 120 healthy donors and 120TB patients derived from different clinical backgrounds RESULTS: The 5-oxoproline level was consistently low in patients with active TB. Further validation in larger population of clinical samples showed that 5-oxoproline was associated with pathological damage of the lung but not with age, sex, or bacterial burden in TB patients. CONCLUSIONS: Serum 5-oxoproline may be a useful biomarker for active TB and pathological damage of the lung.
Authors: Jennifer K Frediani; Dean P Jones; Nestan Tukvadze; Karan Uppal; Eka Sanikidze; Maia Kipiani; ViLinh T Tran; Gautam Hebbar; Douglas I Walker; Russell R Kempker; Shaheen S Kurani; Romain A Colas; Jesmond Dalli; Vin Tangpricha; Charles N Serhan; Henry M Blumberg; Thomas R Ziegler Journal: PLoS One Date: 2014-10-15 Impact factor: 3.240
Authors: Yi Ding; Robert-Jan Raterink; Rubén Marín-Juez; Wouter J Veneman; Koen Egbers; Susan van den Eeden; Mariëlle C Haks; Simone A Joosten; Tom H M Ottenhoff; Amy C Harms; A Alia; Thomas Hankemeier; Herman P Spaink Journal: Sci Rep Date: 2020-07-15 Impact factor: 4.379
Authors: Nicholas J Andreas; Robindra Basu Roy; Maria Gomez-Romero; Verena Horneffer-van der Sluis; Matthew R Lewis; Stephane S M Camuzeaux; Beatriz Jiménez; Joram M Posma; Leopold Tientcheu; Uzochukwu Egere; Abdou Sillah; Toyin Togun; Elaine Holmes; Beate Kampmann Journal: Sci Rep Date: 2020-04-29 Impact factor: 4.379
Authors: Abisola Regina Sholeye; Aurelia A Williams; Du Toit Loots; A Marceline Tutu van Furth; Martijn van der Kuip; Shayne Mason Journal: Front Neurol Date: 2022-03-21 Impact factor: 4.003